Abstract
We have examined collagen from a patient with the rare type IIC form of perinatally lethal osteogenesis imperfecta, in whom biochemical characteristics of hypophosphatasia were also apparent. In addition to normal α1(I) and α2(I) chains, there were chains overmodified along their lengths. Unexpectedly, the thermal stability of molecules containing these chains was normal. This suggests the existence of a structural mutation causing delayed triple helix formation, situated in either the α1(I) or α2(I) C-terminal propeptide. Since collagen synthesised by fibroblasts from each of the patient's parents was normal, the mutation was probably newly arising and dominant. In contrast to other reported cases of lethal osteogenesis imperfecta, not only was the secretion of collagen by cultured fibroblasts considerably retarded, but that of non-collagenous proteins was also severely impaired.
Similar content being viewed by others
Abbreviations
- OI:
-
osteogenesis imperfecta
- EMEM:
-
Eagle's minimum essential medium
- SDS-PAGE:
-
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
- Tm :
-
thermal denaturation temperature
References
Barsh GS, Roush CL, Bonadio J, Byers PH, Gelinas RE (1985) Intron-mediated recombination may cause a deletion in an α1 type I collagen chain in a lethal form of osteogenesis imperfecta. Proc Natl Acad Sci USA 82:2870–2874
Bateman JF, Mascara T, Chan D, Cole WG (1984) Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J 217:103–115
Bateman JF, Chan D, Mascara T, Rogers JG, Cole WG (1986) Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J 240:699–708
Bateman JF, Chan D, Walker ID, Rogers JG, Cole WG (1987) Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the α1(I) chain of type I collagen. J Biol Chem 262:7021–7027
Bonadio J, Byers PH (1985) Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II. Nature 316:363–366
Cetta G, Tenni R, Zanaboni G, DeLuca G, Ippolito E, DeMartino C, Castellani AA (1982) Biochemical and morphological modifications in rabbit Achilles tendon during maturation and ageing. Biochem J 204:61–67
Chu M-L, Gargiulo V, Williams CJ, Ramirez F (1985) Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA. J Biol Chem 260:691–694
Cohn DH, Byers PH, Steinmann B, Gelinas RE (1986) Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human proα1(I) collagen allele. Proc Natl Acad Sci USA 83:6045–6047
Glass EJ, Hume R, Hendry GMA, Strange RC, Forfar JO (1982) Plasma alkaline phosphatase activity in rickets of prematurity. Arch Dis Child 57:373–376
Habuchi H, Conrad HE, Glaser JH (1985) Coordinate regulation of collagen and alkaline phosphatase levels in chick embryo chondrocytes. J Biol Chem 260:13029–13034
Kirsch E, Glanville RW, Krieg T Müller P (1983) Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfacta. Overhydroxylation of lysine residues is found all along the collagen chains. Biochem J 211:599–603
Kivirikko KI, Myllylä R (1982) Post-translational modifications. In: Weiss JB, Jayson MIV (eds) Collagen in health and disease. Churchill Livingstone, Edinburgh, pp 101–120
McKusick VA (1972) Heritable disorders of connective tissue, 4th edn. Mosby, StLouis, pp 390–454
Millan JL, Whyte MP, Avioli LV, Fishman WH (1980) Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred. Clin Chem 26:840–845
Moss DW (1976) Enzyme tests in diseases of bone. In: Wilkinson JH (ed) The principles and practice of diagnostic enzymology. Arnold, London, pp 399–422
Moss DW (1986) Mulliple forms of acid and alkaline phosphatases: genetics, expression and tissue-specific modification. Clin Chim Acta 161:123–135
Moss DW, Shakespeare MJ, Thomas DM (1972) Observations on the heat-stability of alkaline phosphatase isoenzymes in serum. Clin Chim Acta 40:35–41
Peterkofsky B (1972) The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblasts. Arch Biochem Biophys 152:318–328
Prockop DJ, Kuivaniemi H (1986) Inborn errors of collagen. Rheumatology 10:246–271
Rasmussen H (1983) Hypophosphatasia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 1497–1507
Royce PM, Barnes MJ (1977) Comparative studies on collagen glycosylation in chick skin and bone. Biochim Biophys Acta 498:132–142
Royce PM, Steinmann B, Blumberg A, Zurbrügg RP (1986) Low plasma alkaline phosphatase activity in a case of osteogenesis imperfecta (OI) type II (lethal perinatal). Experientia 42:634–635
Sillence D (1981) Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop Relat Res 159:11–25
Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116
Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL (1984) Osteogenesis imperfecta type II. Delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 17:407–423
Smith R, Francis MJO, Houghton GR (1983) The brittle bone syndrome: osteogenesis imperfecta. Butterworths, London
Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann R, Byers PH (1984) Cysteine in the triple-helical domain of one allelic product of the α1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem 259:11129–11138
Thompson EM, Young ID, Hall CM, Pembrey ME (1987) Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta. J Med Genet 24:390–405
Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER (1983) A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem 29:751–761
Trelstad RL, Rubin D, Gross J (1977) Osteogenesis imperfecta congenita. Evidence for a generalized molecular disorder of collagen. Lab Invest 36:501–508
Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, Harris H (1986) Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci USA 83:7182–7186
Wet WJ de, Pihlajaniemi T, Myers J, Kelley TE, Prockop DJ (1983) Synthesis of a shortened pro-α2(I) chain and decreased synthesis of pro-α2(I) chains in a proband with osteogenesis imperfecta. J Biol Chem 258:7721–7728
Young ID, Thompson EM, Hall CM, Pembrey ME (1987) Osteogenesis imperfecta type IIA: evidence for dominant inheritance. J Med Genet 24:386–389
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Royce, P.M., Blumberg, A., Zurbrügg, R.P. et al. Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia. Eur J Pediatr 147, 626–631 (1988). https://doi.org/10.1007/BF00442478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442478